Stocks in News

by khalid on 24/05/2010 · 0 comments

Bull Eye

Bull's Eye

Abbott Laboratories :- The company is acquiring Piramal Healthcare’s domestic formulations business to make the combined entity one of the largest players in the country’s generic drugs market. Abbott will make an upfront payment of $2.12 billion to Piramal Healthcare, apart from $400 million annually for four years. Piramal will retain its business of custom drug manufacturing for third parties, critical care, over the- counter products, pharmaceutical ingredients, vitamin, diagnostic medical devices and clinical research.
Impact on Bull : Positive

IRB Infrastructure :-The company has bagged an order for six-lanning of the Tumkur-Chitradurga section of NH-4 on build, operate and transfer basis. The project is on a premium basis and the estimated project cost is Rs 1,200 crore. IRB Infrastructure gets a concession period of 26 years and has to pay a premium of Rs 140.4 crores to the National Highways Authority of India (NHAI) in the first year.
Impact on Bull : Positive

Godrej Consumer Products Ltd :- The company has signed an agreement to entirely acquire the Argentina-based Issue Group for an undisclosed sum. Apart from Argentina, the Issue Group has a significant presence in Peru, Uruguay and Paraguay, besides a rising one in Brazil in the hair and skin care segments.
Impact on Bull : Positive

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: